Navigating the Ethical Maze: Dr. Arthur Caplan on Bioethics in Modern Medicine episode artwork

EPISODE · Jan 25, 2024 · 1H 9M

Navigating the Ethical Maze: Dr. Arthur Caplan on Bioethics in Modern Medicine

from RealPharma: Conversations with Pharma Pathfinders · host RealPharma

Dr. Arthur Caplan, a distinguished bioethicist, discusses various topics related to bioethics. He highlights the importance of bioethics in areas such as organ transplantation, genetic testing, artificial intelligence, and personalized medicine. Dr. Caplan emphasizes the need for informed consent in research ethics and the importance of providing research participants with the results of studies. He also addresses the ethical considerations in organ transplantation, including the allocation of scarce resources and the role of living donors. Additionally, he discusses the ethical implications of expensive treatments and the allocation of limited resources in healthcare. The conversation explores the disparity in healthcare attention given to rare diseases compared to chronic conditions. It highlights the need for organized advocacy and lobbying for conditions that lack representation. The discussion also delves into the balance between investing in genetic therapies for rare diseases and preventive measures for chronic conditions. The ethical considerations of gene editing using CRISPR technology are examined, including the need for monitoring and surveillance of adverse effects. The potential for societal inequalities in access to gene editing is discussed, raising concerns about eugenics and the widening gap between those who can afford the technology and those who cannot. Chapters00:00 Introduction to Dr. Arthur Caplan 01:35 The Importance of Bioethics in Various Areas 09:25 Informed Consent in Research Ethics 17:29 Balancing Scientific Progress and Ethical Considerations in Human Subject Research 33:41 Ethical Considerations in Organ Transplantation 47:22 Healthcare Resource Utilization and Pricing 48:25 Disparity in Healthcare Attention 51:18 Balancing Rare Diseases and Chronic Conditions 53:36 Genetics vs. Environmental Intervention 58:26 CRISPR and Bioethical Concerns 01:05:13 Societal Inequalities in Access to Gene Editing 01:06:03 Inspiration from Ben Franklin ResourcesDr. Arthur Caplan Succumbing to AI with a whimper, not a bang Working Group on Compassionate Use and Preapproval Access (CUPA) Vaccine Working Group on Ethics and Policy Working Group on Pediatric Gene Therapy & Medical Ethics Transplant Ethics and Policy  If you donate DNA, what should scientists give in return? A ‘pathbreaking’ new model Treating the dead; how far ought medicine go to obtain transplantable organs? Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision? Research involving the recently deceased: ethics questions that must be answered Regaining Trust in Public Health and Biomedical Science following Covid: The Role of Scientists Protect newborn screening programs Why the Gene Was (Mis)Placed at the Center of American Health Policy

Episode metadata supplied by the publisher feed · Published Jan 25, 2024

Embed this episode

Dr. Arthur Caplan, a distinguished bioethicist, discusses various topics related to bioethics. He highlights the importance of bioethics in areas such as organ transplantation, genetic testing, artificial intelligence, and personalized medicine. Dr. Caplan emphasizes the need for informed consent in research ethics and the importance of providing research participants with the results of studies. He also addresses the ethical considerations in organ transplantation, including the allocation of scarce resources and the role of living donors. Additionally, he discusses the ethical implications of expensive treatments and the allocation of limited resources in healthcare. The conversation explores the disparity in healthcare attention given to rare diseases compared to chronic conditions. It highlights the need for organized advocacy and lobbying for conditions that lack representation. The discussion also delves into the balance between investing in genetic therapies for rare diseases and preventive measures for chronic conditions. The ethical considerations of gene editing using CRISPR technology are examined, including the need for monitoring and surveillance of adverse effects. The potential for societal inequalities in access to gene editing is discussed, raising concerns about eugenics and the widening gap between those who can afford the technology and those who cannot. Chapters 00:00 Introduction to Dr. Arthur Caplan 01:35 The Importance of Bioethics in Various Areas 09:25 Informed Consent in Research Ethics 17:29 Balancing Scientific Progress and Ethical Considerations in Human Subject Research 33:41 Ethical Considerations in Organ Transplantation 47:22 Healthcare Resource Utilization and Pricing 48:25 Disparity in Healthcare Attention 51:18 Balancing Rare Diseases and Chronic Conditions 53:36 Genetics vs. Environmental Intervention 58:26 CRISPR and Bioethical Concerns 01:05:13 Societal Inequalities in Access to Gene Editing 01:06:03 Inspiration from Ben Franklin

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Navigating the Ethical Maze: Dr. Arthur Caplan on Bioethics in Modern Medicine

0:00 1:09:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RealPharma: Conversations with Pharma Pathfinders?

This episode is 1 hour and 9 minutes long.

When was this RealPharma: Conversations with Pharma Pathfinders episode published?

This episode was published on January 25, 2024.

Can I download this RealPharma: Conversations with Pharma Pathfinders episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!